Case Studies


Managed the PR strategy for a global genomics service company’s launch in 2008, initial public offering in 2010, and announced acquisition in 2012


Created a global communications academy for research and executive staff at a top 10 pharma company, administered the program, and taught classes

Clinical Trials

Partnered with pharma, research, and academic organizations in the US, UK, and South Africa to communicate technological progress with a tuberculosis candidate vaccine. Activities included context setting for an unsuccessful Phase II clinical trial.

Rare Diseases

Represented an orphan drug while its biologic license application was submitted to the U.S. Food and Drug Administration and withdrawn twice.